The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $0.47 in the prior trading day, Accelerate Diagnostics Inc (NASDAQ: AXDX) closed at $0.14, down -70.39%. In other words, the price has decreased by -$70.39 from its previous closing price. On the day, 8.15 million shares were traded.
Ratios:
Our goal is to gain a better understanding of AXDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.62 and its Current Ratio is at 0.71.
Craig Hallum Upgraded its Hold to Buy on August 07, 2020, while the target price for the stock was maintained at $20.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 04 ’25 when Phillips Jack sold 25,343 shares for $0.65 per share. The transaction valued at 16,473 led to the insider holds 191,374 shares of the business.
Mertz Larry Michael sold 1,523 shares of AXDX for $990 on Apr 04 ’25. The Chief Technology Officer now owns 84,803 shares after completing the transaction at $0.65 per share. On Apr 01 ’25, another insider, Patience David, who serves as the Chief Financial Officer of the company, sold 6,816 shares for $0.71 each. As a result, the insider received 4,839 and left with 64,568 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30.
Stock Price History:
Over the past 52 weeks, AXDX has reached a high of $2.09, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -82.22%, while the 200-Day Moving Average is calculated to be -89.67%.
Shares Statistics:
A total of 25.19M shares are outstanding, with a floating share count of 15.31M. Insiders hold about 39.27% of the company’s shares, while institutions hold 18.14% stake in the company.
